Ken Griffin Optimize Rx Corp Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$8.8 - $13.17 $167,200 - $250,230	19,000 Added 678.57%	21,800 $218,000
Q1 2024 May 15, 2024	SELL	$11.47 - $16.17 $310,837 - $438,207	-27,100 Reduced 90.64%	2,800 $34,000
Q4 2023 Feb 14, 2024	BUY	$7.06 - $14.49 $93,192 - $191,268	13,200 Added 79.04%	29,900 $427,000
Q3 2023 Nov 14, 2023	SELL	$7.43 - $14.96 $592,171 - $1.19 Million	-79,700 Reduced 82.68%	16,700 $129,000
Q2 2023 Aug 14, 2023	SELL	$11.63 - $15.63 $698,963 - $939,363	-60,100 Reduced 38.4%	96,400 $1.38 Million
Q1 2023 May 15, 2023	BUY	$12.54 - $19.38 $1.02 Million - $1.57 Million	81,100 Added 107.56%	156,500 $2.29 Million
Q4 2022 Feb 14, 2023	SELL	$13.77 - $22.04 $1.58 Million - $2.53 Million	-114,900 Reduced 60.38%	75,400 $1.27 Million
Q3 2022 Nov 14, 2022	BUY	$13.74 - $30.13 $1.57 Million - $3.43 Million	114,000 Added 149.41%	190,300 $2.82 Million

13.6M

79.8K

41.4K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $93.9M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.